Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
$80.00
Out of stock
Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)
Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email [email protected] for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at [email protected] with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.
$65.00
$85.00
$25.00
Original price was: $255.00.$190.00Current price is: $190.00.
$20.00
$40.00
$40.00
SLU-PP-332 tablet formulation (50 tablets) provides a compact supply of this ERRα/ERRγ agonist in standardized tablet format optimized for targeted and focused preclinical investigations. Each tablet delivers consistent SLU-PP-332 dosing specifically optimized for initial exploratory studies and preliminary dose-finding research examining estrogen-related receptor signaling pathways and metabolic phenotype modulation. This smaller format effectively supports pilot experiments and focused research protocols examining ERR-dependent metabolic effects and mitochondrial function.
Chemical Specifications:
• Chemical Name: SLU-PP-332 (ERRα/γ agonist)
• Molecular Formula: C17H16N4O3 (approximate)
• Molecular Weight: 324.33 g/mol (approximate)
• Compound Class: Estrogen-related receptor agonist
SLU-PP-332 tablets provide reliable, consistent dosing for controlled experiments investigating mitochondrial biogenesis, metabolic gene expression, and exercise-mimetic signaling pathways. The tablet matrix enables straightforward administration and standardized experimental protocols in preclinical research models.
Research Applications:
• Conducting initial dose-finding studies in preclinical research protocols
• Investigating ERR agonist effects on mitochondrial function and biogenesis
• Characterizing metabolic adaptation mechanisms in controlled laboratory settings
• Examining oxidative metabolism changes in energy expenditure models
• Modeling exercise-induced metabolic signaling in tissue-based assays
Storage and Handling:
• Store at room temperature (20-25°C) in original container
• Maintain in low-humidity, light-protected storage conditions
• Keep tablets dry and protected from moisture exposure
• Prevent exposure to extreme temperatures during storage
Product Specifications:
• Purity: >97% HPLC per tablet
• Form: Compressed tablets
• Appearance: White tablets with uniform characteristics
• Quantity: 50 tablets (approximate 12.5-25 mg total, dosage per tablet unspecified)
FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.
To browse peptidessource.is , please log in to your account or create a new one.
